Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing (A57354) Retirement - Effective August 20, 2022

This coverage article has been retired under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).

Effective Date: August 20, 2022

Summary: The information in this article has been incorporated within the Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer A58679. The previous retirement date of August 08, 2022 has been rescinded and replaced with August 20, 2022.

Visit the Noridian Medicare Coverage Articles webpage to access the Retired articles in the CMS MCD.

Last Updated Jul 12 , 2022